581 related articles for article (PubMed ID: 29300704)
1. Cost-effectiveness and Budget Impact of Specialized Psychotherapy for Borderline Personality Disorder: A Synthesis of the Evidence.
Wetzelaer P; Lokkerbo J; Arntz A; van Aselt T; Smit F; Evers S
J Ment Health Policy Econ; 2017 Dec; 20(4):177-190. PubMed ID: 29300704
[TBL] [Abstract][Full Text] [Related]
2. PRO*BPD: effectiveness of outpatient treatment programs for borderline personality disorder: a comparison of Schema therapy and dialectical behavior therapy: study protocol for a randomized trial.
Fassbinder E; Assmann N; Schaich A; Heinecke K; Wagner T; Sipos V; Jauch-Chara K; Hüppe M; Arntz A; Schweiger U
BMC Psychiatry; 2018 Oct; 18(1):341. PubMed ID: 30340474
[TBL] [Abstract][Full Text] [Related]
3. The cost of borderline personality disorder: societal cost of illness in BPD-patients.
van Asselt AD; Dirksen CD; Arntz A; Severens JL
Eur Psychiatry; 2007 Sep; 22(6):354-61. PubMed ID: 17544636
[TBL] [Abstract][Full Text] [Related]
4. Out-patient psychotherapy for borderline personality disorder: cost-effectiveness of schema-focused therapy v. transference-focused psychotherapy.
van Asselt AD; Dirksen CD; Arntz A; Giesen-Bloo JH; van Dyck R; Spinhoven P; van Tilburg W; Kremers IP; Nadort M; Severens JL
Br J Psychiatry; 2008 Jun; 192(6):450-7. PubMed ID: 18515897
[TBL] [Abstract][Full Text] [Related]
5. The value of psychological treatment for borderline personality disorder: Systematic review and cost offset analysis of economic evaluations.
Meuldijk D; McCarthy A; Bourke ME; Grenyer BF
PLoS One; 2017; 12(3):e0171592. PubMed ID: 28249032
[TBL] [Abstract][Full Text] [Related]
6. Day hospital Mentalization-based treatment versus intensive outpatient Mentalization-based treatment for patients with severe borderline personality disorder: protocol of a multicentre randomized clinical trial.
Laurenssen EM; Smits ML; Bales DL; Feenstra DJ; Eeren HV; Noom MJ; Köster MA; Lucas Z; Timman R; Dekker JJ; Luyten P; Busschbach JJ; Verheul R
BMC Psychiatry; 2014 Nov; 14():301. PubMed ID: 25403144
[TBL] [Abstract][Full Text] [Related]
7. Societal cost-of-illness in patients with borderline personality disorder one year before, during and after dialectical behavior therapy in routine outpatient care.
Wagner T; Fydrich T; Stiglmayr C; Marschall P; Salize HJ; Renneberg B; Fleßa S; Roepke S
Behav Res Ther; 2014 Oct; 61():12-22. PubMed ID: 25113523
[TBL] [Abstract][Full Text] [Related]
8. Population-based cost-offset estimation for the treatment of borderline personality disorder: projected costs in a currently running, ideal health system.
Wunsch EM; Kliem S; Kröger C
Behav Res Ther; 2014 Sep; 60():1-7. PubMed ID: 25014129
[TBL] [Abstract][Full Text] [Related]
9. Psychological therapies including dialectical behaviour therapy for borderline personality disorder: a systematic review and preliminary economic evaluation.
Brazier J; Tumur I; Holmes M; Ferriter M; Parry G; Dent-Brown K; Paisley S
Health Technol Assess; 2006 Sep; 10(35):iii, ix-xii, 1-117. PubMed ID: 16959171
[TBL] [Abstract][Full Text] [Related]
10. An Economic Analysis of Psychotherapy for Borderline Personality Disorder Patients.
Hall J; Caleo S; Stevenson J; Meares R
J Ment Health Policy Econ; 2001 Mar; 4(1):3-8. PubMed ID: 11967460
[TBL] [Abstract][Full Text] [Related]
11. A cost-effectiveness analysis of dialectical behaviour therapy for treating individuals with borderline personality disorder in the community.
Murphy A; Bourke J; Flynn D; Kells M; Joyce M
Ir J Med Sci; 2020 May; 189(2):415-423. PubMed ID: 31482522
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of psychotherapy for cluster C personality disorders: a decision-analytic model in the Netherlands.
Soeteman DI; Verheul R; Meerman AM; Ziegler U; Rossum BV; Delimon J; Rijnierse P; Thunnissen M; Busschbach JJ; Kim JJ
J Clin Psychiatry; 2011 Jan; 72(1):51-9. PubMed ID: 21034679
[TBL] [Abstract][Full Text] [Related]
13. Psychotherapy with borderline patients: II. A preliminary cost benefit study.
Stevenson J; Meares R
Aust N Z J Psychiatry; 1999 Aug; 33(4):473-7; discussion 478-81. PubMed ID: 10483841
[TBL] [Abstract][Full Text] [Related]
14. Regional analysis of health service utilisation by persons with borderline personality disorders: implications for evidence-informed policy.
Ferrer M; Andion O; Bendeck M; Calvo N; Prat M; Aragones E; Barral C; Casas M; Salvador-Carulla L
J Ment Health Policy Econ; 2015 Mar; 18(1):17-25. PubMed ID: 25862205
[TBL] [Abstract][Full Text] [Related]
15. The effectiveness of 6 versus 12-months of dialectical behaviour therapy for borderline personality disorder: the feasibility of a shorter treatment and evaluating responses (FASTER) trial protocol.
McMain SF; Chapman AL; Kuo JR; Guimond T; Streiner DL; Dixon-Gordon KL; Isaranuwatchai W; Hoch JS
BMC Psychiatry; 2018 Jul; 18(1):230. PubMed ID: 30016935
[TBL] [Abstract][Full Text] [Related]
16. Strengthening the status of psychotherapy for personality disorders: an integrated perspective on effects and costs.
Bartak A; Soeteman DI; Verheul R; Busschbach JJ
Can J Psychiatry; 2007 Dec; 52(12):803-10. PubMed ID: 18186181
[TBL] [Abstract][Full Text] [Related]
17. Lamotrigine versus inert placebo in the treatment of borderline personality disorder: study protocol for a randomized controlled trial and economic evaluation.
Crawford MJ; Sanatinia R; Barrett B; Byford S; Cunningham G; Gakhal K; Lawrence-Smith G; Leeson V; Lemonsky F; Lykomitrou G; Montgomery A; Morriss R; Paton C; Tan W; Tyrer P; Reilly JG
Trials; 2015 Jul; 16():308. PubMed ID: 26187496
[TBL] [Abstract][Full Text] [Related]
18. Day Hospital Mentalization-Based Treatment (MBT-DH) versus treatment as usual in the treatment of severe borderline personality disorder: protocol of a randomized controlled trial.
Laurenssen EM; Westra D; Kikkert MJ; Noom MJ; Eeren HV; van Broekhuyzen AJ; Peen J; Luyten P; Busschbach JJ; Dekker JJ
BMC Psychiatry; 2014 May; 14():149. PubMed ID: 24886402
[TBL] [Abstract][Full Text] [Related]
19. Cost-effective psychotherapy for personality disorders in the Netherlands: the value of further research and active implementation.
Soeteman DI; Busschbach JJ; Verheul R; Hoomans T; Kim JJ
Value Health; 2011; 14(2):229-39. PubMed ID: 21296601
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
